Anne Teremi
Medical · Okemos, MINPI 1831278092
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.4% of the total across 704 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 18.3% — the pattern of someone who eats at a lot of different presentations. Among medical clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 704 payments — averaging $16.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$2K
- UCB, Inc.$2K
- Johnson & Johnson$2K
- AbbVie$1K
- AstraZeneca$853
- Novartis$698
- plus $3K from 21 others
What the payments were for
- Food & beverage$11,23297%
- Education$2993%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 134 | $2,116 |
| UCB, Inc. | 94 | $1,610 |
| Johnson & Johnson | 112 | $1,590 |
| AbbVie | 98 | $1,324 |
| AstraZeneca(2 entities) | 44 | $853 |
| Novartis | 41 | $698 |
| Pfizer | 39 | $606 |
| E.r. Squibb & Sons, L.L.C. | 27 | $514 |
| Lilly USA, LLC | 15 | $291 |
| Genentech USA, Inc. | 14 | $244 |
| Sobi, Inc | 12 | $237 |
| Sanofi | 11 | $196 |
| Organon | 9 | $183 |
| Fresenius Kabi USA, LLC | 7 | $180 |
| Radius Health, Inc. | 9 | $174 |
| GSK | 9 | $141 |
| Actelion Pharmaceuticals US, Inc. | 7 | $119 |
| Aurinia Pharma U.S., Inc. | 5 | $92 |
| ANI Pharmaceuticals, Inc. | 4 | $80 |
| Janssen Scientific Affairs, LLC | 1 | $56 |
| Hospira, Inc. | 2 | $50 |
| Alvogen Inc | 3 | $46 |
| Boehringer Ingelheim | 2 | $39 |
| Sandoz | 2 | $39 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $21 |
| Mylan Institutional Inc. | 1 | $19 |
| Biocon Biologics Inc | 1 | $16 |
How this compares
$11,531 in reported general payments places this provider in the 95th percentile of 755 medical providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EnbrelEtanercept | 70 | $509,672 |
| Humira(Cf)Adalimumab | 56 | $426,624 |
| Orencia ClickjectAbatacept | 37 | $214,047 |
| Enbrel SureclickEtanercept | 28 | $212,508 |
| Humira PenAdalimumab | 25 | $195,651 |
| RinvoqUpadacitinib | 27 | $182,520 |
| Cosentyx Sensoready PenSecukinumab | 22 | $150,161 |
| Cosentyx (2 Syringes)Secukinumab | 19 | $141,161 |
| OrenciaAbatacept | 25 | $140,207 |
| Humira(Cf) PenAdalimumab | 20 | $138,391 |
| Cosentyx Unoready PenSecukinumab | 19 | $135,406 |
| Cimzia (2 Pack)Certolizumab Pegol | 21 | $119,304 |
| Xeljanz XrTofacitinib Citrate | 14 | $76,773 |
| TymlosAbaloparatide | 17 | $46,279 |
| Hydroxychloroquine Sulfate | 272 | $15,759 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieHumira(Cf), Rinvoq | $1,324 | $609,14483 claims |
| AmgenEnbrel | $2,116 | $509,67270 claims |
| NovartisCosentyx (2 Syringes) | $698 | $141,16119 claims |
| E.r. Squibb & Sons, L.L.C.Orencia | $514 | $140,20725 claims |
| UCB, Inc.Cimzia (2 Pack) | $1,610 | $119,30421 claims |
| Radius Health, Inc.Tymlos | $174 | $46,27917 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 755 medical providers in Michigan.
Other medical in Okemos
- Timothy SloanOkemos$9K
- Caleb YoungbloodBerkley$215K
- Steven StoneKalamazoo$200K
- Meredith KentGrand Rapids$192K
- Amber ShullNorton Shores$154K
- Jason EvansWaterford$104K
- James ToreySaint Clair Shores$56K
- David WilkinsMuskegon$41K
- Mark RosenBerkley$32K
- Robert DemeesterRoyal Oak$27K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.